Dose reduction and toxicity of lenalidomide-dexamethasone in multiple myeloma: A machine-learning prediction model.

Iván MarayCristina Álvarez-AsteinzaClara Luz Fernández-LagunaLola Macía-RivasMónica Carbajales-ÁlvarezAna Lozano-Blazquez

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Elderly patients and those with low bone marrow reserves are prone to dose-limiting adverse events. This study can aid in making follow-up, prophylaxis, and dosing decisions to achieve better pharmacotherapeutic results.

Keyphrases

multiple myeloma
bone marrow
machine learning
mesenchymal stem cells
low dose
high dose
stem cell transplantation
artificial intelligence
newly diagnosed
big data
deep learning